Advanced Search


Study ID Status Title Patient Level Data
114261 Completed A Clinical Study to Evaluate Potential Biomarkers in Osteoarthritis Patients
114263 Completed A Study of the Efficacy and Safety of Multiple Doses of Dutasteride versus Placebo and Finasteride in the Treatment of Male Subjects with Androgenetic Alopecia Study Listed on
114264 Completed Study ARI114264: A Long-Term Study of the Safety and Efficacy of Dutasteride in the Treatment of Male Subjects with Androgenetic Alopecia Study Listed on
114267 Completed A Phase III randomized, open-label study comparing GSK1120212 to chemotherapy in subjects with advanced or metastatic BRAF V600E/K mutation-positive melanoma
114269 Completed Partially-blind Immunogenicity and Safety Study of GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults. Study Listed on
114270 Completed Immunogenicity and safety study of GSK Biologicals’ influenza vaccine Arepanrix™ (GSK2340274A) in adults 65 years of age or older Study Listed on
114272 Completed A multi-center, placebo-controlled study to evaluate the safety and efficacy of GSK1278863 vs. placebo in subjects with peripheral artery disease (PAD). Study Listed on
114273 Completed DCA114273: A Study Comparing Denosumab with Zoledronic Acid in Subjects of Asian Ancestry with Bone Metastases from Solid Tumors
114292 Completed A phase III study for evaluation of immunogenicity and reactogenicity of Fluarix™/Influsplit SSW® 2010/2011 in people aged 18 years or above Study Listed on
114294 Terminated Observer-blind Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Adjuvanted Quadrivalent Influenza Candidate Vaccines (GSK2584786A) in Children Aged 6 to 35 Months Study Listed on
114296 Completed A Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects with Moderate to Severe Plaque-Type Psoriasis Study Listed on
114306 Completed Immunogenicity and safety of a booster dose of GlaxoSmithKline Biologicals’ IPV (PoliorixTM) in healthy Chinese toddlers Study Listed on
114312 Completed A randomized, double-blind, placebo-controlled, parallel group study to compare GW766944 (an oral CCR3 receptor antagonist) versus placebo in patients with asthma and sputum eosinophilia. Study Listed on
114324 Completed BOTOX®(BOTOX is a registered trade mark of Allergan, Inc) Injection 50 and 100Treatment of Equinus Foot due to Lower Limb Spasticity in Juvenile Cerebral Palsy Patients Aged 2-year or Older:Investigation of Patient Background Characteristics
114332 Completed Drug Use Investigation for Cervarix®
114334 Completed A comparative bioavailability study to compare the pharmacokinetic (PK) and pharmacodynamic (PD) effects of Fluticasone propionate and Salmeterol delivered by Fluticasone propionate/ Salmeterol combination in a capsule-based inhaler and a multi-dose dry powder inhaler, in moderate asthma patients and moderate to severe Chronic obstructive pulmonary disease (COPD) patients. Study Listed on
114341 Completed A phase 2, multi-centre, randomised, double-masked, placebo-controlled, parallel-group study to investigate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of GSK933776 in adult patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD)
114346 Completed A Phase I, Randomized, Placebo-Controlled, Four-Way Crossover Study to Evaluate the Effect of Intravenous (IV) Zanamivir on Cardiac Conduction as Assessed by 12-lead Electrocardiogram (ECG) with Moxifloxacin as a Positive Control in Healthy Volunteers Study Listed on
114347 Completed A single-blind, placebo-controlled study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of repeat ascending doses of GSK2018682 (S1P1 agonist) in healthy volunteers Study Listed on
114350 Completed Study on the MAGE A3 polymorphism and MAGE A3 and PRAME expression levels in Chinese NSCLC patients (NOT FINAL TITLE)
114351 Completed Immunogenicity, reactogenicity and safety study of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus (HRV) vaccine in healthy Taiwanese infants who received hepatitis B immunoglobulin after birth. Study Listed on
114371 Completed Immunogenicity and safety study of GSK Biologicals’ cell culture derived pandemic influenza vaccines GSK2590066A and GSK2592984A administered to healthy adults 18 - 49 years old Study Listed on
114373 Completed A Phase III international, randomized, double-blind, double-dummy study to evaluate the efficacy and safety of 300 mg or 600 mg of intravenous zanamivir twice daily compared to 75 mg of oral oseltamivir twice daily in the treatment of hospitalized adults and adolescents with influenza Study Listed on
114378 Completed Contribution of infectious pathogens to acute respiratory illness in adults and elderly Study Listed on
114379 Completed Safety study of GSK Biologicals’ human papillomavirus vaccine (GSK-580299) in healthy female control subjects from the GSK HPV-023 study



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.